CytomX Therapeutics Faces Listing Rule Issues
Ticker: CTMX · Form: 8-K · Filed: Feb 26, 2025 · CIK: 1501989
| Field | Detail |
|---|---|
| Company | Cytomx Therapeutics, INC. (CTMX) |
| Form Type | 8-K |
| Filed Date | Feb 26, 2025 |
| Risk Level | high |
| Sentiment | bearish |
Sentiment: bearish
Topics: delisting, listing-rules, sec-filing
TL;DR
CytomX might be in trouble with the stock exchange - listing rules are a problem.
AI Summary
CytomX Therapeutics, Inc. filed an 8-K on February 26, 2025, reporting a notice of delisting or failure to satisfy a continued listing rule or standard, with the earliest event reported on February 24, 2025. The company is incorporated in Delaware and its principal executive offices are located in South San Francisco, California.
Why It Matters
This filing indicates potential issues with CytomX Therapeutics' continued listing on a stock exchange, which could impact its stock price and investor confidence.
Risk Assessment
Risk Level: high — A notice of delisting or failure to meet listing standards is a significant negative event that can lead to severe stock price declines and reduced liquidity.
Key Players & Entities
- CytomX Therapeutics, Inc. (company) — Registrant
- February 24, 2025 (date) — Earliest event reported
- February 26, 2025 (date) — Date of report
- South San Francisco, California (location) — Principal executive offices
FAQ
What specific listing rule or standard has CytomX Therapeutics, Inc. failed to satisfy?
The filing does not specify the exact rule or standard that CytomX Therapeutics, Inc. has failed to satisfy, only that a notice has been issued.
What is the earliest date associated with the reported event?
The earliest event reported is dated February 24, 2025.
When was this 8-K form filed with the SEC?
This 8-K form was filed on February 26, 2025.
Where are CytomX Therapeutics, Inc.'s principal executive offices located?
CytomX Therapeutics, Inc.'s principal executive offices are located at 151 Oyster Point Blvd, Suite 400, South San Francisco, California, 94080.
What is the company's IRS Employer Identification Number?
The company's IRS Employer Identification Number is 27-3521219.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on February 26, 2025 regarding CytomX Therapeutics, Inc. (CTMX).